An Act Prohibiting Health Care Providers And Clinical Laboratories From Imposing Out-of-pocket Expenses Based On Estimates Of Charges.
Summary
HB 5172 would amend Connecticut’s general statutes to bar health care providers and clinical laboratories from charging an insured patient a coinsurance, copayment, deductible, or other out-of-pocket amount at the time of service when that charge is based only on an estimate of what the service will cost. Instead, the bill requires that any patient cost-sharing be tied to an amount identified in the actual medical bill for the service or treatment.
In practical terms, the bill is aimed at preventing patients from being asked to pay estimated cost-sharing before the final billed amount is known. It applies to health care services or treatment rendered to insured patients and focuses on providers and clinical labs, rather than insurers directly.
Impact
If enacted, the bill would create a new statutory restriction on billing practices for health care providers and clinical laboratories in Connecticut. It would limit when insured patients can be asked to pay cost-sharing amounts at the point of service, shifting the basis for those charges from estimated charges to amounts reflected in the final medical bill. The measure could affect provider billing workflows, patient collections, and the timing of out-of-pocket payments for insured individuals.
Sentiment
The available record shows no committee transcript or vote history, so there is no documented debate or recorded sentiment to assess. Based on the bill’s text and stated purpose, the measure appears consumer-protective and designed to reduce surprise or premature billing, but the legislative record provided does not show whether it was broadly supported or opposed.
Contention
No specific points of contention are documented in the materials provided. Potential areas of dispute, if raised in committee, would likely involve whether the bill interferes with provider billing practices, how estimates and final bills would be reconciled, and whether the restriction could create administrative burdens for providers and laboratories. However, no speakers, amendments, or votes are available here to identify actual opponents or supporters.